Proteoglycan-LDL interactions: A novel therapeutic target?

Lisa R. Tannock

doi:10.1016/j.atherosclerosis.2013.12.049

Proteoglycan-LDL interactions: A novel therapeutic target?

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Original language	English
Pages (from-to)	232-233
Number of pages	2
Journal	Atherosclerosis
Volume	233
Issue number	1
DOIs	https://doi.org/10.1016/j.atherosclerosis.2013.12.049
State	Published - Mar 2014

Keywords

Atherosclerosis
Biglycan
Decorin
LDL retention
Proteoglycan

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.atherosclerosis.2013.12.049

Cite this

@article{4fbd546012a44a5aa42fafe34015f280,

title = "Proteoglycan-LDL interactions: A novel therapeutic target?",

keywords = "Atherosclerosis, Biglycan, Decorin, LDL retention, Proteoglycan",

author = "Tannock, {Lisa R.}",

year = "2014",

month = mar,

doi = "10.1016/j.atherosclerosis.2013.12.049",

language = "English",

volume = "233",

pages = "232--233",

number = "1",

}

TY - JOUR

T1 - Proteoglycan-LDL interactions

T2 - A novel therapeutic target?

AU - Tannock, Lisa R.

PY - 2014/3

Y1 - 2014/3

KW - Atherosclerosis

KW - Biglycan

KW - Decorin

KW - LDL retention

KW - Proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=84893840741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893840741&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2013.12.049

DO - 10.1016/j.atherosclerosis.2013.12.049

M3 - Comment/debate

C2 - 24529149

AN - SCOPUS:84893840741

SN - 0021-9150

VL - 233

SP - 232

EP - 233

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -

Proteoglycan-LDL interactions: A novel therapeutic target?

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this